SWME NEWS:Welcome [Sign In] To track stocks & more, Register
Financial News
Enter symbol(s) BasicPerformanceReal-time MktDetailedChartResearchOptionsOrder Book Symbol Lookup
Press Release Source: SWISS MEDICA INC.
Swiss Medica Inc.: PMS Escape Product Launched With Large U.S. National Pharmacy Chain Purchase Order
Thursday May 26, 6:00 am ET
TORONTO--(BUSINESS WIRE)--May 26, 2005--Swiss Medica Inc. (OTCBB:SWME - News), is pleased to announce that it has received a purchase order from a large U.S. national pharmacy chain for its U.S.-patented, clinically tested PMS Escape product. PMS Escape will be available throughout the USA early this summer in that pharmacy chain. PMS Escape is the first product to achieve national pharmacy shelf space that was part of the acquisition of Anti-Depression BioHealth Solutions, which was announced in a series of news releases dated April 5, 6, 12 and 13.
"We are excited to launch PMS Escape in our first U.S. national pharmacy," said Wendy Kramer, Swiss Medica's Vice President. "Commencing with a national footprint provides PMS Escape with a strong presence in many of the country's largest markets. We believe this will offer millions of women the opportunity to purchase PMS Escape - a clinically studied, patented, safe and effective product for the normal mood and appetite symptoms associated with premenstrual syndrome."
Specific national pharmacy distribution details will be announced to coincide with the national U.S. advertising launch after the PMS Escape product is widely available on store shelves.
About Swiss Medica Inc.
Swiss Medica commercializes proprietary bioscience products that relieve chronic ailments. We increase our market share through focused distribution strategies in multiple sales channels. Swiss Medica's mission is to be a world leader in the commercialization of life enhancing bioscience products that improve quality of lives. Please visit our websites at www.swissmedica.com, www.O24zone.com and www.pmsescape.com.
Swiss Medica's flagship product, the O24 Essential Oil Pain Neutralizer, holds US Patent #6,444,238B1. The O24 pain relief solution has been used, recommended and praised for its fast-acting and long-lasting benefits by healthcare professionals in the United States, Canada and in Europe. O24 is widely available throughout Canada in leading pharmacies and natural food stores. It is currently sold in an increasing number of pharmacies throughout the United States. Customers can also visit www.O24zone.com, for ordering details and store locators for the nearest pharmacy.
Swiss Medica also manufactures PMSEscape which holds US Patent #'s 5760014 and 5612320. PMSEscape is a specially formulated group of carbohydrates, vitamins and minerals, clinically proven to reduce changes in mood and appetite that women experience during the premenstrual period. Customers can also visit www.pmsescape.com for additional information and ordering details.
Forward-looking statements in this news release are made pursuant to the "Safe Harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, risks relating to the ability to close transactions being contemplated, risks related to international sales and potential foreign currency exchange fluctuations, continued acceptance of Swiss Medica's products, increased levels of competition, technological changes, dependence on intellectual property rights and other risks detailed from time to time in Swiss Medica's periodic reports filed with the United States Securities and Exchange Commission and other regulatory authorities.
SWISS MEDICA INC. (OTC Bulletin Board:SWME - News)
--------------------------------------------------------------------------------
Contact:
Swiss Medica Inc.
Investor Relations Contact:
David Jones
(866) 485-4243
OR
Blue Skye PR, Inc.
Product PR Contact:
Sky Wallen
(813) 732-6869
blueskyeinc@yahoo.com
www.blueskyeinc.com
OR
Stern & Co.
Financial Media Contact:
Stan Froelich
VP, Media Relations
(212) 888-0044
sfroelich@sternco.com
--------------------------------------------------------------------------------
Source: SWISS MEDICA INC.
Email Story
Set News Alert
Print Story
Sponsor Results
Investing My Money: Oil and Natural Gas
Need some smart investing tips? Invest in Northstar Energy in Plano, TX. We are licensed to drill in the states of Texas and Louisiana. Contact us for great investment opportunities.
www.northstarenergyinc.com
Jim Cramer's Stock Investment Picks
Get Cramer's personal portfolio, e-mail alerts sent before he trades. Try it free.
www.thestreet.com
ING Direct - Save Your Money
Earn 3.00% annual percentage yield on an Orange Savings Account. A high-rate investment with no fees, no minimums and no need to change banks. Open online in less than five minutes.
home.ingdirect.com
(What's This?)
Related Quote
SWME.OB 0.31 0.00 News
View Detailed Quote
Delayed 20 mins
Providers - Disclaimer
Related News Stories
· Swiss Medica, Inc.: Large U.S. National Pharmacy Chain Purchase Order for O24 Pain Neutralizer Product Boosts Total Store Count Above 13,000 Level - Business Wire (Wed May 25)
· SWISS MEDICA INC Files SEC form 10QSB, Quarterly Report - EDGAR Online (Mon May 16)
· Swiss Medica Issues Store Count Guidance for O24 Pain Neutralizer Product - Business Wire (Thu May 5)
· Swiss Medica Announces Six-Figure Mexican Distribution Agreement - Business Wire (Tue May 3)
More...
--------------------------------------------------------------------------------
· By industry: Biotech, Health care, Medical/pharmaceutical
Top Stories
· Dow, Nasdaq Seen Opening Higher - AP (8:50 am)
· GDP Up 3.5 Percent; Jobless Claims Rise - AP (8:49 am)
· WTO Clears Iran to Start Membership Talks - AP (7:09 am)
· Costco 3Q Profit Up 6 Percent to $209.8M - AP (8:51 am)
More...
--------------------------------------------------------------------------------
· Most-emailed articles
· Most-viewed articles
Finance Spotlight
·
--------------------------------------------------------------------------------
Copyright © 2005 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright Policy - Ad Feedback
Copyright © 2005 Business Wire. All rights reserved. All the news releases provided by Business Wire are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials by posting, archiving in a public web site or database, or redistribution in a computer network is strictly forbidden.
